Senolytic peptide therapy is an emerging field with ongoing research
Key Takeaways Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed from pineal gland research by Professor Vladimir Khavinson in Russia, with over 40 years of study behind its mechanisms
After quantifying the concentrations of melatonin, serotonin, dopamine, glutamate, and neurotrophic factors using HPLC and ELISA, the results are analyzed using statistical software such as GraphPad Prism
Elevated GH even pituitary-derived GH stimulated by secretagogues can worsen insulin sensitivity transiently, particularly in the first 48 weeks of therapy.9 Adults with existing insulin resistance or prediabetes require close glucose monitoring
Warnings Pancreatitis: Cases of pancreatitis have been reported
If inhibiting mTOR supports longevity, then its easy to assume that mTOR stimulation may shorten lifespans